| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Havencrest Healthcare Partners, L.P. last filed a Form 4 in August 2024, as 10% Owner at TOI. From August 2022 to August 2024, the filings on record show 0 open-market purchases and 24 sales.
Our model assigns Havencrest Healthcare Partners, L.P. a strong insider score of 92/100, based on 68 past trades. Over a 12-month horizon, 98.5% of those trades were profitable, with an average 12-month return of +67.2%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 78,500 | $6.23 | $489,415.00 | -0.5% | -77.2% | -81.7% | |
| Aug 26, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 64,609 | $6.15 | $397,360.08 | -0.4% | -74.9% | -87.0% | |
| Aug 23, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 94,473 | $6.57 | $620,434.13 | -0.6% | -75.9% | -87.5% | |
| Aug 16, 2022 | TOI Oncology Institute, Inc. | 10% Owner | Sell | 50,000 | $6.49 | $324,388.29 | -0.3% | -69.1% | -88.2% |